Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa
This study has been terminated.
(Reactogenicity met study halting criteria)
Sponsor:
University of Maryland
Collaborator:
Program for Appropriate Technology in Health
Information provided by (Responsible Party):
Karen Kotloff, MD, University of Maryland
ClinicalTrials.gov Identifier:
NCT00866476
First received: March 19, 2009
Last updated: January 16, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | February 2010 |
| Primary Completion Date: | February 2010 (Final data collection date for primary outcome measure) |